MEDITECH Announces New AI Use Cases at Customer Leadership Event
New use cases, built on Google technology, support the auto-generation of clinical documentationCANTON, Mass.--(BUSINESS WIRE)--Healthcare leaders were given an advanced...
Year: 2023
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
CHICAGO, IL / ACCESSWIRE / September 26, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Objective Medical Systems Expands Offerings with OMS C3(R) Chronic Care Coordinator
HOUMA, LA / ACCESSWIRE / September 26, 2023 / Objective Medical Systems (OMS), a pioneering health information technology company specializing...
Exo® Introduces a New Age of Ultrasound with Exo Iris™
A first-of-its-kind handheld ultrasound that delivers precise, on-the-go answers from anywhere, creating new care pathways across healthcareSANTA CLARA, Calif.--(BUSINESS WIRE)--Exo...
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
Study Data to Support FDA Submission for the first 365-day Continuous Glucose Monitoring SystemGERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American:...
COTA Announces New Data Platform to Accelerate Cancer Research and Advance Generative AI Models for Cancer Care
Vista will set the standard for automating the abstraction of oncology data critical to accelerate research and build trust in...
Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced...
AcuityMD Launches ‘Pipeline’ to Enable MedTech Commercial Teams to Forecast with Accuracy and Improve Sales Planning
BOSTON--(BUSINESS WIRE)--AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced the launch of Pipeline, a new...
Castle Connolly Releases Castle Connolly Top Hispanic & Latino Doctors 2023
For the first time, list recognizes 234 leading Hispanic and Latino doctors in the nationNEW YORK, NY / ACCESSWIRE /...
Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis
RANCHO SANTA FE, CA / ACCESSWIRE / September 26, 2023 / A leading global pharmaceutical company has partnered with Rancho...
Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
SAN FRANCISCO, CA / ACCESSWIRE / September 26, 2023 / In an effort to shed light on the diverse and...
Holon Solutions and HealtHIE Nevada Team Up to Transform Human-Centric Care Delivery in Nevada
The collaboration will break down data silos in healthcare to improve patient outcomes and provide relief to healthcare teams – so...
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children Analysis Shows Annualized Height Velocity...
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
IR-Med, Inc. Figure 1PressureSafe, a skin color agnostic decision support device, for the early detection of pressure injuriesStudy to address...
As Applications for Opioid Use Disorder (OUD) Treatment Surge, Bicycle Health Makes Population-level Applicant Data Available On New Data Hub
The data hub provides policymakers and advocates with insights into the demographics and history of people seeking treatment to inform...
Signati™ Medical Files IDE Study with FDA
Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An...
Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure LX9211 is an investigational, non-opioid treatment for diabetic peripheral...
XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is being developed by XBiotech as...
BioMech Health Wins Leading Specialists in Healthcare Real-Time Motion Analytics in the GHP Healthcare and Pharma Awards 2023
BioMech recognized for its digital advancements in healthcare, allowing patients and clinicians to quantitatively measure and monitor pre-and post-treatment function...
Synfini, Inc. Spins Out of SRI International to Bring Novel Molecular Discovery Platform to Market
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive SRI Development and $1M in Private Investment, Including...
